Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what’s new and what’s enough

Historically, non-small cell lung cancer (NSCLC) is divided into squamous and nonsquamous subtypes based on histologic features. With a growing number of oncogenic drivers being identified in squamous and nonsquamous NSCLC, this malignancy has been recently divided into several distinct subtypes acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fei, Zhou, Cai-Cun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593374/
https://www.ncbi.nlm.nih.gov/pubmed/26187152
http://dx.doi.org/10.1186/s40880-015-0036-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593374/
https://www.ncbi.nlm.nih.gov/pubmed/26187152
http://dx.doi.org/10.1186/s40880-015-0036-4

Ejemplares similares